SCI (4119.TW) monthly revenue, September 2026
SCI reported revenue of NT$0.16bn for September 2026, up 9.7% from the previous month and up 33.1% from a year earlier. Year-to-date revenue was NT$1.15bn, up 16.6% year on year. It ranked 41 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.16 | 9.7 | 33.1 |